Cargando…

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome

Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Deepak, Prince, Chengyu, Bennett, Carolyn M., Briones, Michael, Lucas, Laura, Russell, Athena, Patel, Kiran, Chonat, Satheesh, Graciaa, Sara, Edington, Holly, White, Michael H., Kobrynski, Lisa, Abdalgani, Manar, Parikh, Suhag, Chandra, Sharat, Bleesing, Jack, Marsh, Rebecca, Park, Sunita, Waller, Edmund K., Prahalad, Sampath, Chandrakasan, Shanmuganathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777200/
https://www.ncbi.nlm.nih.gov/pubmed/34424963
http://dx.doi.org/10.1182/blood.2021012924
_version_ 1784637012904509440
author Kumar, Deepak
Prince, Chengyu
Bennett, Carolyn M.
Briones, Michael
Lucas, Laura
Russell, Athena
Patel, Kiran
Chonat, Satheesh
Graciaa, Sara
Edington, Holly
White, Michael H.
Kobrynski, Lisa
Abdalgani, Manar
Parikh, Suhag
Chandra, Sharat
Bleesing, Jack
Marsh, Rebecca
Park, Sunita
Waller, Edmund K.
Prahalad, Sampath
Chandrakasan, Shanmuganathan
author_facet Kumar, Deepak
Prince, Chengyu
Bennett, Carolyn M.
Briones, Michael
Lucas, Laura
Russell, Athena
Patel, Kiran
Chonat, Satheesh
Graciaa, Sara
Edington, Holly
White, Michael H.
Kobrynski, Lisa
Abdalgani, Manar
Parikh, Suhag
Chandra, Sharat
Bleesing, Jack
Marsh, Rebecca
Park, Sunita
Waller, Edmund K.
Prahalad, Sampath
Chandrakasan, Shanmuganathan
author_sort Kumar, Deepak
collection PubMed
description Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lacking. We describe the immune characteristics of 24 patients with pES and compared them with 22 patients with chronic immune thrombocytopenia (cITP) and 24 healthy controls (HCs). Compared with patients with cITP and HC, patients with pES had increased circulating T-follicular helper cells (cTfh), increased T-cell activation, and decreased naïve CD4(+) T cells for age. Despite normal or high immunoglobulin G (IgG) in most pES at presentation, class-switched memory B cells were decreased. Within the cTfh subset, we noted features of postactivation exhaustion with upregulation of several canonical checkpoint inhibitors. T-cell receptor β chain (TCR-β) repertoire analysis of cTfh cells revealed increased oligoclonality in patients with pES compared with HCs. Among patients with pES, those without a known gene defect had a similar characteristic immune abnormality as patients with defined genetic defects. Similarly, patients with pES with normal IgG had similar T-cell abnormalities as patients with low IgG. Because genetic defects have been identified in less than half of patients with pES, our findings of similar immune abnormalities across all patients with pES help establish a common characteristic immunopathology in pES, irrespective of the underlying genetic etiology.
format Online
Article
Text
id pubmed-8777200
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-87772002022-03-03 T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome Kumar, Deepak Prince, Chengyu Bennett, Carolyn M. Briones, Michael Lucas, Laura Russell, Athena Patel, Kiran Chonat, Satheesh Graciaa, Sara Edington, Holly White, Michael H. Kobrynski, Lisa Abdalgani, Manar Parikh, Suhag Chandra, Sharat Bleesing, Jack Marsh, Rebecca Park, Sunita Waller, Edmund K. Prahalad, Sampath Chandrakasan, Shanmuganathan Blood Immunobiology and Immunotherapy Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lacking. We describe the immune characteristics of 24 patients with pES and compared them with 22 patients with chronic immune thrombocytopenia (cITP) and 24 healthy controls (HCs). Compared with patients with cITP and HC, patients with pES had increased circulating T-follicular helper cells (cTfh), increased T-cell activation, and decreased naïve CD4(+) T cells for age. Despite normal or high immunoglobulin G (IgG) in most pES at presentation, class-switched memory B cells were decreased. Within the cTfh subset, we noted features of postactivation exhaustion with upregulation of several canonical checkpoint inhibitors. T-cell receptor β chain (TCR-β) repertoire analysis of cTfh cells revealed increased oligoclonality in patients with pES compared with HCs. Among patients with pES, those without a known gene defect had a similar characteristic immune abnormality as patients with defined genetic defects. Similarly, patients with pES with normal IgG had similar T-cell abnormalities as patients with low IgG. Because genetic defects have been identified in less than half of patients with pES, our findings of similar immune abnormalities across all patients with pES help establish a common characteristic immunopathology in pES, irrespective of the underlying genetic etiology. American Society of Hematology 2022-01-20 /pmc/articles/PMC8777200/ /pubmed/34424963 http://dx.doi.org/10.1182/blood.2021012924 Text en © 2022 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Immunobiology and Immunotherapy
Kumar, Deepak
Prince, Chengyu
Bennett, Carolyn M.
Briones, Michael
Lucas, Laura
Russell, Athena
Patel, Kiran
Chonat, Satheesh
Graciaa, Sara
Edington, Holly
White, Michael H.
Kobrynski, Lisa
Abdalgani, Manar
Parikh, Suhag
Chandra, Sharat
Bleesing, Jack
Marsh, Rebecca
Park, Sunita
Waller, Edmund K.
Prahalad, Sampath
Chandrakasan, Shanmuganathan
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
title T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
title_full T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
title_fullStr T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
title_full_unstemmed T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
title_short T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
title_sort t-follicular helper cell expansion and chronic t-cell activation are characteristic immune anomalies in evans syndrome
topic Immunobiology and Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777200/
https://www.ncbi.nlm.nih.gov/pubmed/34424963
http://dx.doi.org/10.1182/blood.2021012924
work_keys_str_mv AT kumardeepak tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT princechengyu tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT bennettcarolynm tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT brionesmichael tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT lucaslaura tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT russellathena tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT patelkiran tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT chonatsatheesh tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT graciaasara tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT edingtonholly tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT whitemichaelh tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT kobrynskilisa tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT abdalganimanar tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT parikhsuhag tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT chandrasharat tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT bleesingjack tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT marshrebecca tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT parksunita tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT walleredmundk tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT prahaladsampath tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome
AT chandrakasanshanmuganathan tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome